Publications found:
487
Sort by:
The 2027-2032 World Outlook for Clostridium Diagnostics
US$ 1,195.00
This study covers the world outlook for clostridium diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Dengue Testing
US$ 1,195.00
This study covers the world outlook for dengue testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for E. Coli Testing
US$ 1,195.00
This study covers the world outlook for e. coli testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for ELISA-Based Arbovirus Tests
US$ 1,195.00
This study covers the world outlook for ELISA-based arbovirus tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Enteric Disease Testing
US$ 1,195.00
This study covers the world outlook for enteric disease testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis B Diagnostic Tests
US$ 1,195.00
This study covers the world outlook for hepatitis b diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis Diagnostics
US$ 1,195.00
This study covers the world outlook for hepatitis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Herpes Marker Testing
US$ 1,195.00
This study covers the world outlook for herpes marker testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for HIV-AIDS Confirmatory Tests
US$ 1,195.00
This study covers the world outlook for HIV-AIDS confirmatory tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for HIV-AIDS Monitoring Tests
US$ 1,195.00
This study covers the world outlook for HIV-AIDS monitoring tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for HIV-AIDS Testing
US$ 1,195.00
This study covers the world outlook for HIV-AIDS testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Rabies Diagnostics
US$ 1,195.00
This study covers the world outlook for rabies diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microbiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry), By Pathogen, By End Use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global antimicrobial resistance diagnostics market size was estimated at USD 3.42 billion in 2025 and is expected to reach USD 4.68 billion by 2033, growing at a CAGR of 4.08% from 2026 to 2033....
December 2025
120 pages
Middle East Diagnostic Reagents For Infectious Diseases Market Size, Share & Trends Analysis Report By Product (Molecular Reagents, Immunoassay Reagents), By Disease Area, By Technology, By End Use, By Country, and Segment Forecasts, 2025 - 2033
US$ 5,950.00
The Middle East diagnostic reagents for infectious diseases market size was estimated at USD 77.92 million in 2024, and is projected to reach USD 158.14 million by 2033, growing at a CAGR of 7.6% fro...
December 2025
150 pages
HIV/HBV/HCV Test Kits Market - 2025-2031
US$ 3,400.00
HIV/HBV/HCV Test Kits Market reached USD 8842.48 million in 2031 and, growing with a CAGR of 5.70% during the forecast period 2031-2035. The HIV/HBV/HCV Test Kits Market emerges as a key focus in Data...
December 2025
47 pages
Diagnostic Reagents For Infectious Diseases Market Size, Share & Trends Analysis Report By Product (Molecular Reagents, Immunoassay Reagents), By Disease Area (Respiratory Infections, Enteric Infections), By Technology, By End Use, By Region, and Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global diagnostic reagents for infectious diseases market size was estimated at USD 3,475.31 millionin 2024 and is projected to reach USD 8,079.07 million by 2033, growing at a CAGR of 9.30% from...
November 2025
150 pages
Rapid Pathogen Detection Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Rapid Test Kits, Consumables & Reagents), By Technology (Immunoassays, NAAT), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global rapid pathogen detection diagnostics market size was estimated at USD 21.05 billion in 2024 and is projected to reach USD 30.90 billion by 2033, growing at a CAGR of 4.48% from 2025 to 2033...
November 2025
130 pages
Global Dengue Testing Market - 2025-2033
US$ 3,400.00
Global Dengue Testing Marketis is growing with a CAGR of 4.10% during the forecast period 2026-2035. The Global Dengue Testing Market emerges as a key focus in DataM Intelligence latest in-depth analy...
November 2025
47 pages
Arbovirus Testing Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Instruments, Reagents, Software Services), By Technology (Immunoassay, Molecular Diagnostics, Others, Microbiology), By Application, By Location
US$ 3,950.00
The Arbovirus Testing Market is valued at USD 1.58 billion in 2025 and is projected to grow at a CAGR of 5.3% to reach USD 2.51 billion by 2034. Arbovirus Testing Market The Arbovirus Testing market c...
November 2025
160 pages
Human Immunodeficiency Virus Rapid Test Kits Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Consumables, Instruments, Software, Services), By Test Type (Antibody Tests, HIV-1 Screening Tests, HIV-1 Confirmatory Tests, HIV-2, Group-O-Diagnostic Tests, CD4 Count, Viral Load, Early Infant, Viral Identification), By Application
US$ 3,950.00
The Human Immunodeficiency Virus Rapid Test Kits Market is valued at USD 4.92 billion in 2025 and is projected to grow at a CAGR of 7% to reach USD 9.46 billion by 2034. Human Immunodeficiency Virus R...
November 2025
160 pages
Human Papilloma Virus Testing Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Consumables, Systems), By Valence Type, Bivalent, Quadrivalent, Nonavalent), By Indication, By Distribution Channel, By End-User
US$ 3,950.00
The Human Papilloma Virus Testing Market is valued at USD 2.37 billion in 2025 and is projected to grow at a CAGR of 10.1% to reach USD 5.63 billion by 2034. Human Papilloma Virus Testing Market The H...
November 2025
160 pages
Molecular Infectious Disease Testing Market Outlook 2026-2034: Market Share, and Growth Analysis By Products and Services (Reagents & Kits, Instruments, Services & Software), By Type (Multiplex Testing, Singleplex Testing), By Test Type, By Disease, By Technology, By End-User
US$ 3,950.00
The Molecular Infectious Disease Testing Market is valued at USD 9.58 billion in 2025 and is projected to grow at a CAGR of 14.3% to reach USD 31.9 billion by 2034. Molecular Infectious Disease Testin...
November 2025
160 pages
Point-of-Care Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Rapid Antigen Tests, Molecular Point-of-Care Tests), By Influenza Strain (Influenza A, Influenza B), By Technology, By End-use (Hospitals, Clinics, Homecare Settings), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global point-of-care influenza diagnostics market size was estimated at USD 415.56 million in 2024 and is projected to reach USD 709.52 million by 2033, growing at a CAGR of 6.14% from 2025 to 203...
October 2025
150 pages